Trials / Recruiting
RecruitingNCT07277673
Aerobic Exercise Addition to Cognitive Behavioural Treatment in Impotence Metabolic-syndrome Drinkers
Is There a Benefit of Aerobic Exercise Addition to Cognitive Behavioural Treatment in Heavy Drinking Men With Impotence and Metabolic Syndrome?
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Male
- Age
- 35 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Cognitive Behavioural Treatment is used as treatment for Heavy Drinking, Impotence, and Metabolic Syndrome. The efficacy of adding aerobic training to this treatment is not tested till now.
Detailed description
Forty men with Heavy Drinking, Impotence, and Metabolic Syndrome will be included. catogorization will be performed to assign them to group number I or group number II. Every group will involve/contain twenty males. Both groups will receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks). Also, Group number I will also adminsiter supervised aerobic training (walking on electrical treamill, 50 minute per the session , three times/week, for 12 weeks).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | aerobci physical training and cognitive behavioural treatment | Twenty men with Heavy Drinking, Impotence, and Metabolic Syndrome receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks). Also, men will also adminsiter supervised aerobic training (walking on electrical treamill, 50 minute per the session, three times/week, for 12 weeks). |
| BEHAVIORAL | Cognitive behavioural treatment | Twenty men with Heavy Drinking, Impotence, and Metabolic Syndrome will receive Cognitive Behavioural Treatment (30 minute per the session , three times/week, for 12 weeks) |
Timeline
- Start date
- 2025-10-10
- Primary completion
- 2026-02-15
- Completion
- 2026-02-15
- First posted
- 2025-12-11
- Last updated
- 2025-12-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07277673. Inclusion in this directory is not an endorsement.